Opko Health Stock Gross Profit

OPK Stock

USD 1.58 0.02 1.28%

Opko Health fundamentals help investors to digest information that contributes to Opko Health's financial success or failures. It also enables traders to predict the movement of Opko Stock. The fundamental analysis module provides a way to measure Opko Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Opko Health stock.

	Last Reported	Projected for Next Year
Gross Profit	318.1 M	334 M
Gross Profit Margin	0.37	0.39

Gross Profit is expected to rise to about 334 M this year. Gross Profit Margin is expected to rise to 0.39 this year.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Opko Health Company Gross Profit Analysis

Opko Health's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Gross Profit

Revenue

-

Cost of Revenue

More About Gross Profit | All Equity Analysis

Current Opko Health Gross Profit

214.3 M

Most of Opko Health's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Opko Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Opko Gross Profit Driver Correlations

Understanding the fundamental principles of building solid financial models for Opko Health is extremely important. It helps to project a fair market value of Opko Stock properly, considering its historical fundamentals such as Gross Profit. Since Opko Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Opko Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Opko Health's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Intangible Assets	Short Term Debt	Common Stock	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Long Term Debt	Short Term Investments	Net Receivables	Good Will	Net Tangible Assets	Capital Surpluse	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		1.0	0.1	-0.64	0.86	0.98	0.77	0.92	0.52	0.8	0.65	0.89	0.71	0.65	-0.53	0.87	0.97	0.19	0.91	0.65	0.37	0.39	-0.25	0.27	0.3
Total Stockholder Equity	1.0		0.05	-0.62	0.84	0.96	0.76	0.91	0.51	0.78	0.67	0.88	0.75	0.61	-0.51	0.87	0.97	0.18	0.9	0.67	0.38	0.36	-0.23	0.26	0.28
Net Debt	0.1	0.05		-0.71	0.39	0.22	0.0	-0.06	0.56	0.53	0.3	0.36	-0.29	0.53	-0.11	0.05	0.08	0.76	0.35	-0.32	0.28	0.67	-0.34	0.32	0.76
Retained Earnings	-0.64	-0.62	-0.71		-0.78	-0.67	-0.49	-0.41	-0.91	-0.94	-0.6	-0.8	-0.25	-0.74	0.46	-0.54	-0.63	-0.81	-0.84	-0.05	-0.65	-0.84	0.49	-0.5	-0.88
Accounts Payable	0.86	0.84	0.39	-0.78		0.87	0.77	0.68	0.64	0.83	0.68	0.94	0.46	0.61	-0.41	0.9	0.86	0.53	0.89	0.26	0.42	0.65	-0.43	0.48	0.55
Total Liab	0.98	0.96	0.22	-0.67	0.87		0.76	0.91	0.54	0.82	0.61	0.87	0.6	0.74	-0.55	0.84	0.93	0.23	0.9	0.58	0.35	0.45	-0.27	0.3	0.34
Total Current Assets	0.77	0.76	0.0	-0.49	0.77	0.76		0.7	0.36	0.61	0.49	0.65	0.3	0.54	-0.41	0.89	0.71	0.25	0.74	0.25	0.22	0.49	-0.62	0.7	0.27
Intangible Assets	0.92	0.91	-0.06	-0.41	0.68	0.91	0.7		0.27	0.59	0.53	0.72	0.65	0.64	-0.49	0.77	0.89	-0.11	0.79	0.69	0.2	0.25	-0.07	0.1	0.01
Short Term Debt	0.52	0.51	0.56	-0.91	0.64	0.54	0.36	0.27		0.85	0.48	0.68	0.27	0.62	-0.44	0.43	0.53	0.74	0.71	0.05	0.87	0.74	-0.35	0.39	0.82
Common Stock	0.8	0.78	0.53	-0.94	0.83	0.82	0.61	0.59	0.85		0.52	0.84	0.41	0.74	-0.67	0.65	0.75	0.65	0.88	0.29	0.57	0.69	-0.43	0.45	0.75
Treasury Stock	0.65	0.67	0.3	-0.6	0.68	0.61	0.49	0.53	0.48	0.52		0.75	0.44	0.45	0.15	0.65	0.69	0.42	0.76	0.21	0.45	0.52	-0.3	0.33	0.44
Property Plant Equipment	0.89	0.88	0.36	-0.8	0.94	0.87	0.65	0.72	0.68	0.84	0.75		0.59	0.64	-0.41	0.85	0.92	0.48	0.93	0.36	0.5	0.63	-0.28	0.3	0.51
Current Deferred Revenue	0.71	0.75	-0.29	-0.25	0.46	0.6	0.3	0.65	0.27	0.41	0.44	0.59		0.14	-0.29	0.51	0.77	-0.12	0.58	0.79	0.36	-0.06	0.25	-0.28	0.0
Long Term Debt	0.65	0.61	0.53	-0.74	0.61	0.74	0.54	0.64	0.62	0.74	0.45	0.64	0.14		-0.44	0.49	0.63	0.41	0.77	0.23	0.45	0.75	-0.27	0.33	0.54
Short Term Investments	-0.53	-0.51	-0.11	0.46	-0.41	-0.55	-0.41	-0.49	-0.44	-0.67	0.15	-0.41	-0.29	-0.44		-0.38	-0.47	-0.1	-0.45	-0.39	-0.2	-0.22	0.13	-0.14	-0.2
Net Receivables	0.87	0.87	0.05	-0.54	0.9	0.84	0.89	0.77	0.43	0.65	0.65	0.85	0.51	0.49	-0.38		0.86	0.27	0.82	0.36	0.31	0.46	-0.37	0.46	0.26
Good Will	0.97	0.97	0.08	-0.63	0.86	0.93	0.71	0.89	0.53	0.75	0.69	0.92	0.77	0.63	-0.47	0.86		0.2	0.93	0.62	0.44	0.45	-0.12	0.16	0.29
Net Tangible Assets	0.19	0.18	0.76	-0.81	0.53	0.23	0.25	-0.11	0.74	0.65	0.42	0.48	-0.12	0.41	-0.1	0.27	0.2		0.48	-0.41	0.48	0.78	-0.55	0.57	0.96
Capital Surpluse	0.91	0.9	0.35	-0.84	0.89	0.9	0.74	0.79	0.71	0.88	0.76	0.93	0.58	0.77	-0.45	0.82	0.93	0.48		0.4	0.56	0.7	-0.36	0.39	0.58
Long Term Investments	0.65	0.67	-0.32	-0.05	0.26	0.58	0.25	0.69	0.05	0.29	0.21	0.36	0.79	0.23	-0.39	0.36	0.62	-0.41	0.4		0.09	-0.28	0.35	-0.34	-0.23
Short Long Term Debt	0.37	0.38	0.28	-0.65	0.42	0.35	0.22	0.2	0.87	0.57	0.45	0.5	0.36	0.45	-0.2	0.31	0.44	0.48	0.56	0.09		0.57	-0.1	0.17	0.58
Long Term Debt Total	0.39	0.36	0.67	-0.84	0.65	0.45	0.49	0.25	0.74	0.69	0.52	0.63	-0.06	0.75	-0.22	0.46	0.45	0.78	0.7	-0.28	0.57		-0.49	0.57	0.8
Net Invested Capital	-0.25	-0.23	-0.34	0.49	-0.43	-0.27	-0.62	-0.07	-0.35	-0.43	-0.3	-0.28	0.25	-0.27	0.13	-0.37	-0.12	-0.55	-0.36	0.35	-0.1	-0.49		-0.96	-0.5
Net Working Capital	0.27	0.26	0.32	-0.5	0.48	0.3	0.7	0.1	0.39	0.45	0.33	0.3	-0.28	0.33	-0.14	0.46	0.16	0.57	0.39	-0.34	0.17	0.57	-0.96		0.52
Capital Stock	0.3	0.28	0.76	-0.88	0.55	0.34	0.27	0.01	0.82	0.75	0.44	0.51	0.0	0.54	-0.2	0.26	0.29	0.96	0.58	-0.23	0.58	0.8	-0.5	0.52

Click cells to compare fundamentals

Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.

Competition

Predict Opko Health

Gross Profit Over Time

According to the company disclosure, Opko Health reported 214.3 M of gross profit. This is 90.45% lower than that of the Biotechnology sector and 76.01% lower than that of the Health Care industry. The gross profit for all United States stocks is 99.22% higher than that of the company.

Opko Gross Profit Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Opko Health's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Opko Health could also be used in its relative valuation, which is a method of valuing Opko Health by comparing valuation metrics of similar companies.

Opko Health is currently under evaluation in gross profit category among its peers.

Opko Health Current Valuation Drivers

We derive many important indicators used in calculating different scores of Opko Health from analyzing Opko Health's financial statements. These drivers represent accounts that assess Opko Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Opko Health's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	875.3M	2.5B	3.1B	898.8M	1.1B	1.4B
Enterprise Value	1.0B	2.7B	3.2B	959.1M	1.4B	1.5B

Opko Fundamentals

	Return On Equity	-0.0939
	Return On Asset	-0.0897
	Profit Margin	(0.19) %
	Operating Margin	(0.62) %
	Current Valuation	1.17 B
	Shares Outstanding	672.8 M
	Shares Owned By Insiders	54.45 %
	Shares Owned By Institutions	28.02 %
	Number Of Shares Shorted	95.86 M
	Price To Earning	7.46 X
	Price To Book	0.76 X
	Price To Sales	1.49 X
	Revenue	863.5 M
	Gross Profit	214.3 M
	EBITDA	(65.52 M)
	Net Income	(188.86 M)
	Cash And Equivalents	210.46 M
	Cash Per Share	0.27 X
	Total Debt	326.56 M
	Debt To Equity	0.16 %
	Current Ratio	2.30 X
	Book Value Per Share	2.06 X
	Cash Flow From Operations	(28.2 M)
	Short Ratio	33.99 X
	Earnings Per Share	(0.19) X
	Price To Earnings To Growth	(2.87) X
	Target Price	3.96
	Number Of Employees	3.93 K
	Beta	1.65
	Market Capitalization	1.06 B
	Total Asset	2.01 B
	Retained Earnings	(2.01 B)
	Working Capital	109.42 M
	Current Asset	454.06 M
	Current Liabilities	251.9 M
	Net Asset	2.01 B

About Opko Health Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Opko Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Opko Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Opko Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Opko Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Opko Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Opko Health Stock. Highlighted below are key reports to facilitate an investment decision about Opko Health Stock:

How To Invest In Opko

Details

Is Opko Stock a good investment?

Details

What is Opko Health's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Opko Health Piotroski F Score and Opko Health Altman Z Score analysis.

For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.

You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.191

Earnings Share

(0.19)

Revenue Per Share

0.998

Quarterly Revenue Growth

(0.03)

Return On Assets

(0.09)

The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Opko Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Opko Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opko Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Opko Health Stock Gross Profit

Opko Health Company Gross Profit Analysis

Gross Profit

Revenue

-

Cost of Revenue

Current Opko Health Gross Profit

Opko Gross Profit Driver Correlations

Opko Gross Profit Peer Comparison

Opko Health Current Valuation Drivers

Opko Fundamentals

About Opko Health Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY